Management of Treatment-Related Intermittent Partial Small Bowel Obstruction: The Use of Octreotide

Journal of Pain and Symptom Management

Volumn 39, Issue 4, 2010, Pages

  Myers, Jeff ^a   Tamber, Anoo ^a   Farhadian, Macey ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ABDOMINAL DISTENSION; ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; BRACHYTHERAPY; CASE REPORT; COLONOSCOPY; CONSTIPATION; DISEASE SEVERITY; EMERGENCY WARD; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTESTINE OBSTRUCTION; LETTER; MALIGNANT BOWEL OBSTRUCTION; NAUSEA; NONMALIGNANT BOWEL OBSTRUCTION; NOSE FEEDING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; RADIATION DOSE; SALPINGOOOPHORECTOMY; SMALL INTESTINE OBSTRUCTION; VOMITING;

ABDOMINAL PAIN; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; OCTREOTIDE; TREATMENT OUTCOME;

EID: 77950916695     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.11.309     Document Type: Letter

References (11)

1. Mercadante S. Assessment and management of mechanical bowel obstruction. In: Portenoy R.K., and Bruera E. (Eds). Topics in palliative care vol. 1 (1997), Oxford University Press, New York, NY 13-16
2. Mercadante S., and Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage 7 (1992) 496-498
3. Cascinu S., Del Ferro E., and Catalano G. A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. Br J Cancer 71 (1995) 97-101
4. Ripamonti C.I., Easson A.M., and Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 44 (2008) 1105-1115
5. Neville R., Fielding P., Cambria R.P., and Modin I. Vascular responsiveness in obstructed gut. Dis Colon Rectum 34 (1991) 229-235
6. Nellgard P., Bojo L., and Cassuto J. Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction. Scand J Gastroenterol 30 (1995) 464-469
7. Basson M.D., Fielding L.P., Bilchik A.J., et al. Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?. Am J Surg 157 (1989) 109-115
8. Reichlin S. Somatostatin. N Engl J Med 309 (1983) 1495-1501
9. Matulonis U.A., Seiden M.V., Roche M., et al. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage 30 (2005) 563-569
10. Diaz Jr. J.J., Bokhari F., Mowery N.T., Acosta J.A., and Block E.F. Guidelines for management of small bowel obstruction. J Trauma 64 (2008) 1651-1664
11. Zhang Y., Gao Y., Ma Q., et al. Randomised clinical trial investigating the effects of combined administration of octreotide and methylglucamine diatrizoate in the older persons with adhesive small bowel obstruction. Dig Liver Dis 38 (2006) 188-194